Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Alcoholic

Explore clinical trials studying Hepatitis, Alcoholic. Study availability and eligibility vary by location and protocol.

70 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Alcoholic trial results

Completed

A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis

NCT03432260

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +7 more
Locations
  • DURECT Study Site 0001 San Diego, California, United States
  • DURECT Study Site 007 Miami, Florida, United States
  • DURECT Study Site 0004 Atlanta, Georgia, United States
  • DURECT Study Site 0002 Chicago, Illinois, United States
View Trial Details
Completed

A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment

NCT04563026

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +7 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Southern California Research Center Coronado, California, United States
  • Keck Hospital of University of Southern California (USC) Los Angeles, California, United States
View all 68 locations
View Trial Details
Completed

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

NCT01143246

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Ascites, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner Good Samaritan Medical Center/Liver Disease Center Phoenix, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Arizona Medical Center South Campus Tucson, Arizona, United States
View all 73 locations
View Trial Details

Related conditions